TABLE 3.
Weighted decay τw of mIPSCs analyzed before and after bath application of the non-α4 selective BDZ agonist LZM (10 µM) or the α4 selective BDZ agonist RO15-4513 (10 µM) to hippocampal slices from control or 48 h 3α,5β-THP-treated female rats
Pre-drug τw, ms | Post-drug τw, ms | |
---|---|---|
Control | ||
LZM | 11.2 ± 3.0 | 22.4 ± 1.30* |
RO 15-4513 | 11.2 ± 3.0 | 8.7 ± 0.6* |
48 h | ||
3α,5β-THP | ||
LZM | 8.79 ± 1.2 | 13.1 ± 0.9* |
RO 15-4513 | 8.79 ± 1.2 | 20.3 ± 3.3* |
All recordings were carried out at 27°C. Values were averaged from individual cell means for each condition (n = 2,000 mIPSCs, 15–25 cells/group, 6–15 rats/group). τw, time constants; LZM, lorazepam.
P < 0.05 vs. control values.